or Try an Advanced Search...

    Anti Diabetic Drugs Stocks List

    Symbol Grade Name % Change
    NVO B Novo Nordisk A/S -1.04
    TERN B Terns Pharmaceuticals, Inc. 6.80
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Obesity Peptide Hormones Bile Acid Chronic Liver Diseases Diabetes Diabetes Care Endocrine System Glucagon Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hepatitis Hormone Therapy Hormones Inflammation Insulin Life Sciences Liver

    Related ETFs - A few ETFs which own one or more of the above listed Anti Diabetic Drugs stocks.

    Symbol Grade Name Weight
    OZEM D Roundhill GLP-1 & Weight Loss ETF 24.0
    EDEN A iShares MSCI Denmark Capped ETF 22.95
    PPH B Market Vectors Pharmaceutical ETF 10.02
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.56
    PJIO B PGIM Jennison International Opportunities ETF 7.63
    View all Anti Diabetic Drugs ETFs...
    Compare ETFs
    Compare EDEN to PJIO Compare EDEN to PPH Compare OZEM to PJIO

        Anti Diabetic Drugs Stocks Recent News

        Date Stock Title
        May 29 NVO Catalent shareholders approve acquisition by Novo Holdings
        May 29 NVO Jim Cramer Recommends Buying Apple, Finds This Tech Stock 'Very Interesting'
        May 29 NVO Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
        May 28 NVO Nvidia, advances in cancer research, climate change under Trump: Market Domination
        May 28 NVO Sector Update: Health Care Stocks Fall Late Afternoon
        May 28 NVO SSE’s wind farm fined record £33m for pushing up household bills
        May 28 NVO Sector Update: Health Care Stocks Retreat Tuesday Afternoon
        May 28 NVO Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System
        May 28 NVO Dow Jones Tech Giant Apple, AI Leader CrowdStrike Eye Buy Points
        May 28 NVO Novo blames pharma middlemen over Wegovy pricing: Bloomberg News
        May 28 NVO Market Chatter: Novo Nordisk Tells US Senate Health Committee Chair Sanders It Only Keeps 60% of Ozempic, Wegovy List Price
        May 28 NVO Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now?
        May 28 NVO Novo Nordisk: The Market Is Right, Don't Fight Against It
        May 28 NVO Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study
        May 28 NVO Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows
        May 27 NVO Chinese Scientists Achieve World's First Diabetes Cure Using Cell Therapy: Report
        May 27 NVO The Biggest Biotechnology Company in Europe
        May 27 NVO Novo Nordisk: Considerable Growth Beyond Ozempic
        May 26 NVO SA Asks: Who will launch the next big weight-loss drug?
        May 26 NVO Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Obesity Peptide Hormones Bile Acid Chronic Liver Diseases Diabetes Diabetes Care Endocrine System Glucagon Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hepatitis Hormone Therapy Hormones Inflammation Insulin Life Sciences Liver
        Anti Diabetic Drugs

        Anti-diabetic drugs are medications used to treat people with diabetes mellitus. They work by either increasing the amount of insulin produced by the body, or by helping the body use the insulin it produces more effectively. Common types of anti-diabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors.

        Browse All Tags